0) Reference strategy – Treat all with clopidogrel for one year – this is equivalent to our “no testing” I believe
inputs$vPreemptive = "None", inputs$vReactive = "None", inputs$vSwitch = "None"
inputs$clopidogrel$vDAPT.Start = "Clopidogrel"

1) No genotyping; Treat all with alternative antiplatelet for one year
inputs$vPreemptive = "None", inputs$vReactive = "None", inputs$vSwitch = "None"
inputs$clopidogrel$vDAPT.Start = "Ticagrelor"

2) No genotyping; Treat all with alternatives for one month then switch
inputs$vPreemptive = "None", inputs$vReactive = "None", inputs$vSwitch = "All"
inputs$clopidogrel$vDAPT.Start = "Ticagrelor"

3) Genotype at time of PCI and then treat non-LOF with clopidogrel; LOF with Alt
inputs$vPreemptive = "Panel", inputs$vReactive = "None", inputs$vSwitch = "None"
inputs$clopidogrel$vProbabilityDAPTSwitch = 1

4) Treat all patients with alternative until 30 days; then genotype and then switch non-LOF to clopidogrel



general revision:

inputs:
1.time horizon -> 1 year 
2.add drug inputs control (vDAPT.Start)
3.add strategy element "Switch"
4.register 30-day event
5.set drug switch prob to 1 

dapt-events:
2.revise assign_DAPT_medication
4.add 30-day event

initial-patient-attributes:
4.add switch to shut down 30d event once triggered
